STAGE IV RENAL CELL CANCER AJCC V8
Clinical trials for STAGE IV RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a probiotic boost a cancer drug? new trial tests the combo
Disease control Not yet recruitingThis phase 2 trial tests whether adding a probiotic capsule (MO-03) to the drug zanzalintinib can help treat metastatic kidney cancer that has worsened after immunotherapy. About 34 adults with advanced clear cell renal cell carcinoma will receive both treatments. The goal is to …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 23, 2026 19:32 UTC
-
New drug combo aims to boost immune attack on kidney tumors before surgery
Disease control Not yet recruitingThis phase II trial is testing whether giving two immunotherapy drugs, botensilimab and balstilimab, before surgery is safe and feasible for people with high-risk clear cell kidney cancer that hasn't spread. The 16 participants will receive the drugs before their kidney removal s…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Cold sore virus turned against kidney tumors in new trial
Disease control Not yet recruitingThis study tests a combination of two treatments for people with advanced kidney cancer that has spread and stopped responding to immunotherapy. The first treatment, RP2, is a modified cold sore virus designed to infect and destroy cancer cells while also activating the immune sy…
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
Could a cheaper, Lower-Dose immunotherapy work just as well for advanced cancers?
Disease control Not yet recruitingThis study tests whether giving a lower dose of the immunotherapy drug nivolumab less often can still control advanced cancers that have spread or cannot be removed. About 50 adults with various cancers (like melanoma, lung, or kidney cancer) will receive the treatment. The goal …
Matched conditions: STAGE IV RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC